Analyst Ratings for ArriVent BioPharma (AVBP)
AVBP Rating Summary
AVBP Price Target Summary
- Highest: $50.00 (Oppenheimer)
- Lowest: $18.00 (Guggenheim)
- Average: $33.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$33.00 (+57.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/29/2026 | Truist Securities » Updated 10/7/2026 |
Supawat Thongthip | New Coverage | Buy (N/A) |
18.00 (45.00) |
26.97 (21.00) |
-22.14% | Details |
| 4/6/2026 | Jones Trading | Boris Peaker | New Coverage | Buy (N/A) |
45.00 (N/A) |
24.89 (21.00) |
-15.63% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
